对甜味剂的时间性质的药理学视角
1dsm-firmenich, 10636 Scripps Summit Court #201, San Diego, CA 92131, USA.
Pharmacological research
|May 14, 2024
概括
非热量甜味剂可能会导致延迟甜味和持久的味道,因为它们具有较高的受体结合亲和力和较慢的动力学. 这些特性与碳水化合物甜味剂不同,与时间感知问题有关.
科学领域:
- 食品科学 食品科学 食品科学
- 感官科学 感官科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 无热量甜味剂往往会延迟甜味的产生,并留下持久的后味.
- 假设这些时间感官特性源于与口腔膜和蛋白质的相互作用.
研究的目的:
- 研究受体亲和和和结合动力学在甜味剂的时间感知中的作用.
- 为了比较非热量甜味剂的结合特性与碳水化合物甜味剂的时间问题.
主要方法:
- 对各种甜味剂的结合亲和度数据的分析.
- 绑定动力学模拟以模拟受体协会和解离率.
- 应用药理学原理来解释感官观察.
主要成果:
- 与时间问题相关的非热量甜味剂的结合亲和力明显高于碳水化合物甜味剂.
- 有约束力的动力学模拟显示,这些非热量甜味剂的结合和解离率较慢.
- 较高的亲和力与较低的使用水平相关,并影响结合动力学.
结论:
- 受体结合亲和力和动力学是导致某些非热量甜味剂延迟发作和持久后味的关键因素.
- 药理学原则为理解这些时间感官现象提供了一个框架.
- 了解这些机制可以为开发具有更好的感官配置文件的甜味剂提供信息.
关键词:
阿凡坦姆 (PubChem CID: 56843846) 的使用情况亚斯巴甜 (PubChem CID: 134601) 的使用情况甘基 (PubChem CID: 14982) 的使用情况莫格罗赛德V (PubChem CID: 24721270) 提供了更多信息.尼奥斯佩里丁二甲 (PubChem CID: 30231) 的使用情况尼奥他姆 (PubChem CID: 9810996) 是一种天然化学物质.菲洛杜尔 (PubChem CID: 146694) 是一种药物.SC-45647 (PubChem CID: 13960828) 这是一本书.苏克拉 (PubChem CID: 71485) 的使用情况糖 (PubChem CID: 5988) 的使用情况味觉受体是一种味觉受体.这是一个有约束力的约束.折扣价格的折扣 折扣价格的折扣在定价上.甜味剂 甜味剂 甜味剂 甜味剂时间 时间 时间 时间时间强度时间强度.相关概念视频
The Physiology of Taste
3.8K
The perception of a salty flavor is facilitated by sodium ions within the oral salivary fluid. Upon consumption of a salty substance, salt crystals disassemble, leading to the liberation of its constituents—Na+ and Cl- ions. These ions subsequently dissolve into the salivary fluid present in the oral cavity. The external environment of the gustatory cells experiences an elevation in Na+ concentration, thereby establishing a potent concentration gradient. This gradient propels the...
3.8K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Gustation
47.8K
Gustation is a chemical sense that, along with olfaction (smell), contributes to our perception of taste. It starts with the activation of receptors by chemical compounds (tastants) dissolved in the saliva. The saliva and filiform papillae on the tongue distribute the tastants and increase their exposure to the taste receptors.
47.8K
Taste Buds and Receptors
1.9K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
1.9K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
126
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
126
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K


